Navigation Links
EU Recognizes Importance of ASI's Research on Developing New Smart Imaging Molecular Tools for Combating Neurodegenerative Diseases
Date:2/16/2010

MIGDAL HAEMEK, Israel, Feb. 16 /PRNewswire/ -- Neurodegenerative diseases such as Alzheimer's set a challenge for modern medicine, as their origins are unclear and the comprehension of the progression of symptoms often relies upon a patients' behavior.

Applied Spectral Imaging (ASI) a leading provider of comprehensive imaging solutions for Pathology and Cytogenetics, was chosen by the European Union (EU) to be one out of nine industry and academia groups to form the Lupas consortium. ASI possess unique spectral technology that labels each region of the image with multiple colors beyond the basic red, green and blue colors that are available today in digital cameras.

LUPAS seeks to develop new smart imaging molecular tools for combating neurodegenerative diseases. Via modern imaging technology, development and validation of novel, properly functionalized, luminescent conjugated polymers (LCPs) can give rise to entirely new and innovative methodology that can be used for biomedical research, diagnosis, monitoring and prognosis, and for support and guidance of therapeutic interventions for Alzheimer's disease and prior diseases. ASI harnesses its unique capabilities within "Lupas" to help identify and characterize amyloids that form the accumulation of plaques and proteins in the brain, usually associated with Alzheimer patients.

The consortium is composed of expert groups in experimental optics, polymer synthesis, magnetic resonance imaging (MRI), and synthesis of functionalized magnetic nanoparticles, amyloid structure, AD mouse models, clinical AD and prior diseases. This project establishes strategic links between mainly SME based Industries, expert researchers at universities and principal users in terms of hospitals. The project consortium will develop and share an efficient plan for dissemination and exploitation of the project results.

Limor Siphosh, CEO of ASI, " We hope that by the end of the third year, we will have a better understanding of Alzheimer's disease, 'mad cow disease' and others. Knowledge will bring recognition and in time the ability to accurately diagnose and treat these diseases."  

About ASI

Applied Spectral Imaging (ASI), is a leading developer and manufacturer of comprehensive solutions for Pathology and Cytogenetics imaging, computer aided technology and data management needs. ASI was founded in 1993; it is a privately held company with two fully owned subsidiaries that manage sales and customer support in North America and Europe, along with independent distributors throughout the rest of the world. The company owns more than 25 patents in the US alone, and other patents in Europe and Japan.  These patents cover general use spectral imaging, image analysis, scanning techniques, spectroscopy in life science and medicine and patents for specific applications.

For further information: www.spectral-imaging.com

Media Contact: IDAN Communications;

Keren Wulich: +972-9-9514666 or keren@idancom.com

SOURCE Applied Spectral Imaging (ASI)

RELATED LINKS
http://www.spectral-imaging.com

'/>"/>

SOURCE Applied Spectral Imaging (ASI)
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
2. Science Magazine Recognizes Monsanto as Top Employer
3. National Academy of Sciences Recognizes Monsantos Chief Technology Officer for Development of Agricultural Biotechnology
4. FactPoint Group Recognizes Halogen for "On-Choice" Deployment Model
5. New Study Recognizes Halogen Customer for Best Practices in Employee Performance and Talent Management
6. American Urological Association (AUA) Clinical Guidelines Recognizes Cryotherapy as Treatment Option for Prostate Cancer Patients
7. The NCIIA Recognizes Collegiate Biomedical Engineering Innovations
8. Frost & Sullivan Recognizes Kionixs Dominance in the MEMS Accelerometers Market Through Product Line Strategy
9. Clontech Laboratories, Inc. Recognizes the 2008 Winners of the Nobel Prize in Chemistry
10. Collegiate Inventors Competition(R) Recognizes Top Student Inventors
11. Cleveland Clinic Recognizes Circulating Tumor Cell Technology as Top Medical Innovation for 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2017)...  Kinexum, a distinguished resource for research, development and ... of Thomas C. Seoh as President and ... founder, who becomes Executive Chairman and will continue to ... Thomas Seoh commented, "I am excited ... lead the firm,s remarkable team of life science professionals, ...
(Date:4/26/2017)... (PRWEB) , ... April 26, 2017 , ... ... FDA’s GMP expectations for phase I clinical trials comes to Tampa, San Francisco ... biotechnology and pharma professionals representing FDA regulated organizations such as Pfizer Inc., Teva ...
(Date:4/26/2017)... ... 2017 , ... NextSteps 2017, NetDimensions’ annual global user conference, ... May on the following dates: , ?    London, UK from May 10-11, ?    New Orleans, ... Performance Institute will be the opening keynote speaker at the NextSteps EMEA ...
(Date:4/25/2017)... , ... April 25, 2017 , ... As part of ... series will explore the laboratory testing for DIC in order to illuminate this clinical ... which can occur in hospitalized patients resulting in a high degree of morbidity and ...
Breaking Biology Technology:
(Date:4/5/2017)... 2017 KEY FINDINGS The global ... a CAGR of 25.76% during the forecast period of ... factor for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is ... geography. The stem cell market of the product is ...
(Date:3/30/2017)... The research team of The Hong Kong Polytechnic University (PolyU) ... ground breaking 3D fingerprint minutiae recovery and matching technology, pushing contactless ... use in identification, crime investigation, immigration control, security of access and ... ... A research team led by Dr Ajay Kumar ...
(Date:3/27/2017)... March 27, 2017  Catholic Health Services (CHS) ... Systems Society (HIMSS) Analytics for achieving Stage 6 ... sm . In addition, CHS previously earned a ... using an electronic medical record (EMR). ... level of EMR usage in an outpatient setting.  ...
Breaking Biology News(10 mins):